A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients
Clinical trial NCT06453668 · TERMINATED
Trial details
- NCT number
- NCT06453668
- Sponsor
- ITB-Med LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2026-07-02
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.